Cite Filings / DYN / 0000950170-22-003290

Feed Companies Filings Check

Sign in

10-K

Annual Report

Dyne Therapeutics, Inc. Filed 2022-03-10 Acc 0000950170-22-003290

Documents 1

10-K Annual Report , dyn-20211231.htm

Around this filing

2023-03-02 10-K Annual Report
2022-03-14 4 See Remarks sold 3,384 shares at $8.73 ($29,542)
2022-03-14 4 Chief Scientific Officer sold 693 shares at $8.73 ($6,050)
2022-03-10 S-8 Securities Offered to Employees in Benefit Plans
2022-03-10 8-K Results of operations
2022-03-10 10-K Annual Report
2021-03-04 10-K Annual Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)
SEC Structured Data (opens in new tab)

Loading dyn-20211231.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…